Pharma Intelligence Centre News Today

The FDA granted orphan drug status to Intercept’s therapy, which combines the approved Ocaliva with another drug called bezafibrate.

VLA15 could tip the scales against Lyme disease, but public perception of tick-borne disease vaccines remains critical

By GlobalData Healthcare 06 May 2021 (Last Updated May 6th, 2021 14:34) The US is the most lucrative market for prescription drugs, routinely generating more than 50% of global sales in multiple therapy areas, including oncology. In the past five years, the Food and Drug Administration (FDA) has approved 88 innovator or new formulation drugs in oncology, few of which have made it into Japan and even fewer into China. Share Arti...